Evidence map›Paper›PMID 42908546›Full record

ArticleFrontiers in cardiovascular medicine2026

Paclitaxel retention of drug-coated balloons in veins and arteries under arteriovenous fistula hemodynamics.

Linda B Liu, Kayla Lowry, Brystol Habermacher, Saami K Yazdani

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Linda B LiuDepartment of Biomedical Engineering, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
Kayla LowryDepartment of Engineering, Wake Forest University, Winston-Salem, NC, United States.
Brystol HabermacherDepartment of Engineering, Wake Forest University, Winston-Salem, NC, United States.
Saami K YazdaniDepartment of Engineering, Wake Forest University, Winston-Salem, NC, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Arteriovenous fistulas (AVFs) are the preferred vascular access for hemodialysis, but venous stenosis remains a major limitation to long-term patency. Drug-coated balloons (DCBs) have emerged as a promising therapy to inhibit neointimal hyperplasia and reduce restenosis. However, inconsistent clinical outcomes have limited their adoption for AVF stenosis. The unique AVF environment-characterized by high flow, turbulent shear stress, and alternating arterial and venous segments-may influence drug transfer and retention within the vessel wall. Despite its importance, the impact of tissue type under AVF-specific hemodynamics on DCB performance remains poorly understood. This study investigates paclitaxel retention in venous and arterial tissue under simulated AVF conditions using an Materials and methods: The IN.PACT™ AV paclitaxel-coated balloon was deployed for 2 min in porcine veins and arteries within an Results: Hemodynamic conditions were comparable between venous and arterial groups, confirming physiologically relevant AVF flow and pressure. On log-transformed tissue paclitaxel concentrations, no statistically significant difference was detected between tissue types at either time point (two-way ANOVA, Conclusion: This study establishes an

Indexed as

arteriovenous fistuladialysis accessdrug-coated balloonex vivo modelpaclitaxelpharmacokineticsvascular bioreactor

Identifiers

PMID42908546
PMCPMC13682988

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.